ApprovalTrail

Drug · DIN 02456508

SINEX COMPLETE

SOLUTION

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since May 21, 2021.
Drug Identification Number (DIN)
02456508
Company (DIN owner)
Procter & Gamble Inc.Cincinnati, Ohio, United States
Schedule
Non-prescription drugs
Dosage form
Spray
Route
Nasal
Therapeutic class (ATC)
Oxymetazoline R01AA05
Class
Human
Record last updated
August 14, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
OXYMETAZOLINE HYDROCHLORIDE0.05 %W/V